Company news

Harmony Biosciences Holdings, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

John C. Jacobs, President and CEO of Harmony Biosciences, Joins Life Sciences Pennsylvania Board of Directors

May 17, 2021

Harmony Biosciences to Present at the Oppenheimer Rare and Orphan Disease Summit

May 17, 2021

Harmony Biosciences Reports First Quarter 2021 Results and Business Updates

May 10, 2021

Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting

April 26, 2021

Harmony Biosciences Announces Date of First Quarter 2021 Financial Results

April 26, 2021

Harmony Biosciences To Present WAKIX® (Pitolisant) Data At The 2021 AAN Annual Meeting

April 11, 2021

Harmony Biosciences Launches Grant Program To Address Inequities In The Delivery Of Healthcare In Patients With Sleep Disorders

April 6, 2021

Harmony Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Business Updates

March 24, 2021

Harmony Biosciences Hosts Summit Which Sheds Light on Impact of Sleep Disruption in Rare Diseases

March 18, 2021

Harmony Biosciences Highlights Publication of WAKIX® (pitolisant) Efficacy Data in Sleep Medicine

March 16, 2021

Harmony Biosciences Appoints Sandip Kapadia as Chief Financial Officer

March 14, 2021

Harmony Biosciences Announces Date Of Fourth Quarter And Full Year 2020 Financial Results

March 3, 2021

Harmony Biosciences Certified As A Great Place To Work For The Third Year In A Row

March 1, 2021

Harmony Biosciences To Be Added To Russell 2000® And Russell 3000® Indexes

December 16, 2020

Harmony Biosciences Enrolls First Patient In Phase 2 Trial Evaluating Pitolisant For Excessive Daytime Sleepiness In Patients With Prader-Willi Syndrome

December 14, 2020

Harmony Biosciences Reports Third Quarter 2020 Financial Results and Business Updates

November 11, 2020

Harmony Biosciences Appoints Mark Graf And Eric Motley To Its Board Of Directors

November 10, 2020

Harmony Biosciences Announces Date Of Third Quarter 2020 Financial Results

October 27, 2020

Harmony Biosciences Receives FDA Approval For Expanded Use Of WAKIX® (pitolisant) For The Treatment Of Cataplexy In Adult Patients With Narcolepsy

October 13, 2020

Harmony Biosciences Announces Recipients Of 2020 Patients At The Heart Grant On Second Annual World Narcolepsy Day

September 21, 2020

Harmony Biosciences Presents Efficacy And Safety Analyses For WAKIX® (pitolisant) At Virtual SLEEP 2020

August 27, 2020

Harmony Biosciences To Present New Data For WAKIX® (pitolisant) At SLEEP 2020 Annual Meeting

August 23, 2020

Harmony Biosciences Announces Closing Of Its Upsized Initial Public Offering And Exercise In Full Of Underwriters' Option To Purchase Additional Shares

August 20, 2020

Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering

August 17, 2020

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 29 decks. Every deck is listed under its year.